KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Depreciation & Amortization (CF) (2016 - 2025)

Idexx Laboratories has reported Depreciation & Amortization (CF) over the past 17 years, most recently at $38.7 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $38.7 million for Q4 2025, up 14.88% from a year ago — trailing twelve months through Dec 2025 was $145.2 million (up 11.73% YoY), and the annual figure for FY2025 was $145.2 million, up 11.73%.
  • Depreciation & Amortization (CF) for Q4 2025 was $38.7 million at Idexx Laboratories, up from $36.6 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for IDXX hit a ceiling of $38.7 million in Q4 2025 and a floor of $25.1 million in Q1 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $28.9 million (2022), compared with a mean of $30.3 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): fell 0.95% in 2023 and later increased 17.76% in 2024.
  • Idexx Laboratories' Depreciation & Amortization (CF) stood at $27.7 million in 2021, then rose by 3.7% to $28.7 million in 2022, then increased by 3.54% to $29.7 million in 2023, then rose by 13.35% to $33.7 million in 2024, then grew by 14.88% to $38.7 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $38.7 million (Q4 2025), $36.6 million (Q3 2025), and $35.8 million (Q2 2025) per Business Quant data.